Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07810231

Prospective Longitudinal Cohort Study of Implant Age, Pocket Plane, Incision, Surface Texture, and Volume as Predictors of Clinically Significant Capsular Contracture

This prospective breast implant surveillance cohort will evaluate whether implant age, pocket plane, incision route, surface texture, and volume predict clinically significant capsular contracture. Women with Baker grade I or II aesthetic implants at enrollment will undergo standardized annual assessments for up to five years. The primary outcome is time to incident Baker grade III or IV contracture. Progression, pain, imaging, treatment, and patient-reported outcomes will also be described.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

IQ interquirofanos

Medellín, Colombia

Location status: Recruiting

Location contact

juan Velez, MD, Plastic surgeon

CONTACT

[email protected]

+573054511588

About this study

Women with aesthetic breast implants and no clinically significant contracture at cohort entry will be enrolled into a dynamic surveillance cohort. Operative and device information will be verified from records. Trained assessors will apply a locked Baker grading protocol annually, supported by photographs, symptom assessment, and imaging. Suspected incident Baker III/IV contracture will undergo independent confirmation and operative verification when available. Delayed-entry survival models will estimate the independent effects of implant age, plane, incision, texture, and volume while accounting for bilateral implants and competing implant removal.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female sex and age 18 years or older.
  • Aesthetic breast augmentation with permanent silicone or saline implants under the final protocol.
  • Baker grade I or II in the analyzed breast at cohort entry, confirmed by standardized examination.
  • Known implantation date or year and known pocket plane, incision route, surface texture, and volume.
  • Ability to complete annual clinical assessment for up to five years.
  • Written informed consent.

Exclusion criteria

  • Baker grade III or IV contracture at cohort entry in the analyzed breast.
  • Reconstructive implantation after mastectomy or major trauma.
  • Tissue expander.
  • Active breast infection or open wound at enrollment.
  • Planned immediate implant exchange or explantation.
  • Missing core implant or operative data.

Treatment and study plan

Breast Implant Exposure

Device

Implant-level data include age, laterality, material, surface texture, shape, volume, pocket plane, incision route, primary or revision placement, manufacturer/lot when available, and concomitant mastopexy or fat grafting. Linked arm/group(s): Breast Implant Capsule Surveillance Cohort.

Standardized Capsular Contracture Assessment

Diagnostic Test

Two trained assessors will apply a standardized Baker grading protocol, with breast firmness, distortion, pain, and imaging recorded. Suspected grade III/IV events will undergo central review or operative confirmation when surgery occurs. Linked arm/group(s): Breast Implant Capsule Surveillance Cohort.

Primary outcomes

  1. Time to Incident Baker Grade III or IV Capsular Contracture

    Time frame: From cohort entry through years of prospective follow-up. 10 years

    Implant-level time from cohort entry to the first confirmed clinically significant contracture. Grade III is visible distortion/firmness and grade IV includes pain under the locked examination manual. Bilateral implants will be clustered by participant.

Secondary outcomes

  1. Capsular Contracture-Free Survival by Implant Age

    Time frame: Prospective follow-up through 10 years

    Probability of remaining free of Baker grade III/IV contracture at prespecified implant ages, estimated with delayed-entry survival methods when prevalent implants are included.

Study contacts

Contact information is provided by the study sponsor or research team.

Juan Velez, MD, Plastic surgeon

CONTACT

[email protected]

+57 3054511588

Sponsors and collaborators

Lead sponsor

Research Inc

Industry

Registry information

Important dates

Study start
2014
Primary completion
2026
Study completion
2026
First posted
Sep 9, 2026
Registry last updated
Sep 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.